Host sialylated glycan receptor (Sia-glycan)

Host sialylated glycan receptors are carbohydrate structures terminating in sialic acid (N-acetylneuraminic acid) found on the surface of epithelial cells in the respiratory and gastrointestinal tracts. These glycans serve as the primary attachment point for the influenza virus hemagglutinin (HA) protein, which initiates the viral entry process. The specificity of the HA protein for different glycosidic linkages—typically alpha-2,3-linked sialic acids for avian strains and alpha-2,6-linked sialic acids for human-adapted strains—is a critical determinant of host range and tissue tropism (Source: PubMed, PMID: 22726510). In the context of disease, these receptors are exploited by influenza viruses to facilitate endocytosis and subsequent infection. Therapeutic strategies involve either blocking the viral proteins that bind these glycans or using sialidases to enzymatically strip the receptors from the host cell surface to prevent viral docking (Source: NIH, StatPearls - Influenza). Understanding the distribution and density of these receptors is vital for predicting the pandemic potential of emerging zoonotic influenza viruses.

Other names

Sialic acid-containing glycansSialylated glycoconjugatesInfluenza virus receptorsAlpha-2,3-linked sialic acidAlpha-2,6-linked sialic acidNeu5Ac receptors

Drugs typically target the viral proteins that interact with these receptors rather than the receptors themselves; Neuraminidase inhibitors prevent the cleavage of sialic acid to stop viral release, while sialidase-based biologics (like DAS181) enzymatically remove the sialic acid receptors from the host cell surface to prevent viral attachment.